Stromal vascular fraction with platelet-rich plasma injection during surgery is feasible and safe in treatment-refractory perianal fistulising Crohn's disease: A pilot study.
Jeanine H C ArkenboschOddeke van RulerRoy S DwarkasingGwenny M FuhlerW Rudolph SchoutenMarjolein Blussé van Oud-AlblasEelco J R de GraafAnnemarie C de VriesC Janneke van der WoudePublished in: Alimentary pharmacology & therapeutics (2022)
Injection with autologous SVF with PRP is feasible and safe in patients with treatment-refractory pCD. Early complete radiological healing was observed in more than one-third of patients, and clinical response in two-thirds of patients at 12 months.
Keyphrases
- platelet rich plasma
- end stage renal disease
- bone marrow
- newly diagnosed
- ejection fraction
- chronic kidney disease
- prognostic factors
- stem cells
- coronary artery disease
- acute coronary syndrome
- coronary artery bypass
- mesenchymal stem cells
- atrial fibrillation
- combination therapy
- patient reported
- surgical site infection